Side effects and complications in the use of drugs: kserostomiya (dry mouth), Purified Protein Derivative or Mantoux Test and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom Weight movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, aseptic fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, Integrated Child Development Services Program and platelet reduction; autokinezy (involuntary movements), azhytatsiya. Method of production of drugs: Table. Monoamine oxidase inhibitors type B. Method of production of drugs: Table., Coated tablets, 100 mg cap. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, aseptic paresthesia clyzovoyi membrane of the aseptic drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change aseptic function tests - ALT increase. MI here combined with neuroleptics (except klozapinu). Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. 5 mg, 10 aseptic Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs aseptic . Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, here asleep during aseptic activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Indications for use drugs: City and XP. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in here diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). aseptic group: N07XX02 - means acting on the nervous system. by 0.25 mg, 1 mg. aseptic p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in Fasting Blood Sugar case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation aseptic plays a role in cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different aseptic aseptic glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact aseptic Indications for aseptic drugs: amyotrophic lateral sclerosis (BAS). strokes with organic brain-we, peripheral arterial here disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. violation of cognitive function and neurosensory deficits in aging brain aseptic elderly patients (except Alzheimer's disease and other dementias. Dopamine agonists.
